NR1I2 and cholestasis: The nuclear receptors farnesoid X receptor (FXR), peroxisome proliferator-activated receptor α (PPARα), and pregnane X receptor (PXR) are modifiers of bile formation and, at present, are under investigation as promising targets for therapeutic interventions in cholestasis.